JSP191
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JSP191, covering 2025-08-26 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia [Phase 1, Phase 2]